BioGaia Logo

BioGaia

A healthcare and biotechnology company developing clinically proven probiotic products.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0000470395 (+2 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm

Description

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2010-08-17 09:07 English 622.5 KB
2010-08-17 07:59 Swedish 621.6 KB
2010-07-22 08:55
Ny studie publicerad: Lactobacillus reuteri Protectis effektivt vid kronisk för…
Swedish 259.3 KB
2010-07-22 08:55
New study published: Lactobacillus reuteri Protectis effective in infants with …
English 297.6 KB
2010-06-10 09:49
Ny studie presenterad om Lactobacillus reuteri Protectis
Swedish 237.1 KB
2010-06-10 09:49
New study presented on Lactobacillus reuteri Protectis
English 234.1 KB
2010-06-03 13:44
BioGaia tecknar avtal för Kina
Swedish 245.3 KB
2010-06-03 13:44
BioGaia signs agreement for China
English 250.3 KB
2010-05-26 14:27
BioGaia anmäler nytt antal aktier
Swedish 220.5 KB
2010-05-26 14:27
Change in number of shares in BioGaia AB
English 232.6 KB
2010-05-10 13:15
Ny studie publicerad: Lactobacillus reuteri Protectis minskade symptom i mag-ta…
Swedish 229.3 KB
2010-05-10 13:15
New study published: Lactobacillus reuteri Protectis reduced gastrointestinal s…
English 238.3 KB
2010-05-07 09:05
Årsstämma i BioGaia
Swedish 231.8 KB
2010-05-07 09:05
Annual General Meeting of BioGaia
English 237.5 KB
2010-05-06 13:15 Swedish 516.4 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioGaia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

Cuprina Holdings (Cayman) LTD Logo
Biomedical firm developing wound care biotherapy and cosmeceutical products.
United States of America
CUPR
Curanex Pharmaceuticals Inc Logo
Develops botanical drugs for inflammatory diseases like ulcerative colitis.
United States of America
CURX
Curasight A/S Logo
A clinical-stage biotech developing a theranostic platform for cancer diagnosis and treatment.
Denmark
CURAS
Curevac Logo
A biopharmaceutical company developing therapies based on messenger RNA (mRNA) technology.
Germany
CVAC
CureVac N.V. Logo
A biopharmaceutical company developing mRNA-based medicines for a range of diseases.
United States of America
CVAC
CURIS INC Logo
Biotechnology company developing and commercializing therapeutics for cancer treatment.
United States of America
CRIS
Curocell Inc. Logo
A clinical-stage biotech developing CAR-T therapies for blood cancers.
South Korea
372320
CYBIN INC. Logo
A late-stage neuropsychiatry company developing psychedelic-based therapeutics.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Develops personalized biofeedback therapies for treatment-resistant depression.
United States of America
CYCN
Cyfuse Biomedical K.K. Logo
Develops scaffold-free bio 3D printing technology for tissue and organ fabrication.
Japan
4892

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.